4//SEC Filing
Gresham Gwendolyn 4
Accession 0001209191-23-001063
CIK 0001000229other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 5:02 PM ET
Size
8.7 KB
Accession
0001209191-23-001063
Insider Transaction Report
Form 4
Transactions
- Exercise/Conversion
Common Shares
2022-12-31−12,000→ 19,783 total - Exercise/Conversion
Performance Shares
2022-12-31−12,000→ 0 totalExercise: $0.00→ Common Shares (12,000 underlying) - Tax Payment
Common Shares
2022-12-31$20.27/sh+4,722$95,715→ 15,061 total
Footnotes (1)
- [F1]These shares were awarded as restricted performance shares in February 2020, subject to a three-year performance period that began on January 1, 2020 and ended on December 31, 2022. All requirements for 100% vesting have been met and thus the restricted shares vested on December 31, 2022 at the conclusion of the performance period.
Documents
Issuer
CORE LABORATORIES N V
CIK 0001000229
Entity typeother
Related Parties
1- filerCIK 0001842114
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 5:02 PM ET
- Size
- 8.7 KB